Video Conferencing Dysmorphia: Assessment of Pandemic-Related Body Dysmorphia and Implications for the Post-lockdown Era

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2022 Apr 12

PMID 35411264

Authors

Ashish Sarangi

Swarada Yadav

Jayasudha Gude

Wail Amor

Affiliations

Soon will be listed here.

Abstract

Background: The coronavirus 2019 (COVID-19) pandemic has led to global effects on human interaction and mental health. The most drastic changes are seen in ways people continue to stay connected with each other. Video-conferencing applications like Zoom gained popularity and have become the primary means of communication for social or work events and meetings. These applications have also in many places replaced face-to-face healthcare visits and have penetrated school-based learning. The long-term implications of this digital technology on self-esteem and body image require further study.

Main Body: Video-conferencing applications have led to people being more conscious of their appearance and this has resulted in increased cases of body dysmorphic disorder (BDD). There is increased focus on body appearance and cosmetic procedures to fix minor defects. Although the treatment for BDD is like depression, it requires the personalization of therapy specific to the needs of the patient.

Conclusion: In this review, we aim to highlight the impact of the pandemic on body image and the long-term implications of virtual conferencing. The review also highlights available pharmacological and non-pharmacological treatment approaches in the management of body dysmorphic disorder related to virtual video conferencing.

Citing Articles

Videoconferencing Dysmorphia: The Impact on Self-perception and Desire for Cosmetic Procedures.

Patel P, Szeto M, OConnor K, De La Garza H, Kennedy K, Maymone M J Clin Aesthet Dermatol. 2025; 18(1):46-51.

PMID: 39830830 PMC: 11741173.

Postrhinoplasty Depression: A Systematic Review.

Alhajress R, Obeid D, Alhedaithy A, Assiri H, Alarfaj A Plast Reconstr Surg Glob Open. 2024; 12(11):e6321.

PMID: 39600328 PMC: 11595636. DOI: 10.1097/GOX.0000000000006321.

Zoom dysmorphia in medical students: the role of dysmorphic concern and self-efficacy in online environments amidst COVID-19 pandemic.

Mosalanejad L, Karimian Z, Ayaz R, Maghsodzadeh S, Sefidfard M BMC Med Educ. 2024; 24(1):1330.

PMID: 39563282 PMC: 11577837. DOI: 10.1186/s12909-024-06300-6.

Staying isolated indoors means that nobody sees me": ontological (in)security and living with significant appearance concerns before, during, and 'since' COVID-19.

Edwards C, Mahoney B, Richardson E, Lowe B Int J Qual Stud Health Well-being. 2024; 19(1):2374779.

PMID: 38958499 PMC: 11225628. DOI: 10.1080/17482631.2024.2374779.

Consumer attitudes toward aging skin during the COVID-19 pandemic.

Yang L, Knoll J, Kundu R Int J Womens Dermatol. 2023; 9(3):e095.

PMID: 37457381 PMC: 10348726. DOI: 10.1097/JW9.0000000000000095.

References

Gunstad J, Phillips K . Axis I comorbidity in body dysmorphic disorder. Compr Psychiatry. 2003; 44(4):270-6. PMC: 1613797. DOI: 10.1016/S0010-440X(03)00088-9. View

Conroy M, Menard W, Fleming-Ives K, Modha P, Cerullo H, Phillips K . Prevalence and clinical characteristics of body dysmorphic disorder in an adult inpatient setting. Gen Hosp Psychiatry. 2008; 30(1):67-72. PMC: 2225586. DOI: 10.1016/j.genhosppsych.2007.09.004. View

Enander J, Andersson E, Mataix-Cols D, Lichtenstein L, Alstrom K, Andersson G . Therapist guided internet based cognitive behavioural therapy for body dysmorphic disorder: single blind randomised controlled trial. BMJ. 2016; 352:i241. PMC: 4737850. DOI: 10.1136/bmj.i241. View

Phillips K, Albertini R, Rasmussen S . A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Arch Gen Psychiatry. 2002; 59(4):381-8. DOI: 10.1001/archpsyc.59.4.381. View

Phillips K, Keshaviah A, Dougherty D, Stout R, Menard W, Wilhelm S . Pharmacotherapy Relapse Prevention in Body Dysmorphic Disorder: A Double-Blind, Placebo-Controlled Trial. Am J Psychiatry. 2016; 173(9):887-95. PMC: 5009005. DOI: 10.1176/appi.ajp.2016.15091243. View

Grant J, Kim S, Crow S . Prevalence and clinical features of body dysmorphic disorder in adolescent and adult psychiatric inpatients. J Clin Psychiatry. 2001; 62(7):517-22. DOI: 10.4088/jcp.v62n07a03. View

Rice S, Siegel J, Libby T, Graber E, Kourosh A . Zooming into cosmetic procedures during the COVID-19 pandemic: The provider's perspective. Int J Womens Dermatol. 2021; 7(2):213-216. PMC: 8072483. DOI: 10.1016/j.ijwd.2021.01.012. View

Phillips K, Nierenberg A, BRENDEL G, Fava M . Prevalence and clinical features of body dysmorphic disorder in atypical major depression. J Nerv Ment Dis. 1996; 184(2):125-9. DOI: 10.1097/00005053-199602000-00012. View

Lu S, Bartlett S . On facial asymmetry and self-perception. Plast Reconstr Surg. 2014; 133(6):873e-881e. DOI: 10.1097/PRS.0000000000000211. View

10.

Veale D, Gledhill L, Christodoulou P, Hodsoll J . Body dysmorphic disorder in different settings: A systematic review and estimated weighted prevalence. Body Image. 2016; 18:168-86. DOI: 10.1016/j.bodyim.2016.07.003. View

11.

Pope C, Pope H, Menard W, Fay C, Olivardia R, Phillips K . Clinical features of muscle dysmorphia among males with body dysmorphic disorder. Body Image. 2006; 2(4):395-400. PMC: 1627897. DOI: 10.1016/j.bodyim.2005.09.001. View

12.

Veale D, Gournay K, Dryden W, Boocock A, Shah F, Willson R . Body dysmorphic disorder: a cognitive behavioural model and pilot randomised controlled trial. Behav Res Ther. 1996; 34(9):717-29. DOI: 10.1016/0005-7967(96)00025-3. View

13.

Phillips K, Menard W, Pagano M, Fay C, Stout R . Delusional versus nondelusional body dysmorphic disorder: clinical features and course of illness. J Psychiatr Res. 2005; 40(2):95-104. PMC: 2809249. DOI: 10.1016/j.jpsychires.2005.08.005. View

14.

Wilhelm S, Phillips K, Fama J, Greenberg J, Steketee G . Modular cognitive-behavioral therapy for body dysmorphic disorder. Behav Ther. 2011; 42(4):624-33. PMC: 3320734. DOI: 10.1016/j.beth.2011.02.002. View

15.

Dyl J, Kittler J, Phillips K, Hunt J . Body dysmorphic disorder and other clinically significant body image concerns in adolescent psychiatric inpatients: prevalence and clinical characteristics. Child Psychiatry Hum Dev. 2006; 36(4):369-82. PMC: 1613832. DOI: 10.1007/s10578-006-0008-7. View

16.

Angelakis I, Gooding P, Panagioti M . Suicidality in body dysmorphic disorder (BDD): A systematic review with meta-analysis. Clin Psychol Rev. 2016; 49:55-66. DOI: 10.1016/j.cpr.2016.08.002. View

17.

Pfund G, Hill P, Harriger J . Video chatting and appearance satisfaction during COVID-19: Appearance comparisons and self-objectification as moderators. Int J Eat Disord. 2020; 53(12):2038-2043. DOI: 10.1002/eat.23393. View

18.

ROSEN J, Reiter J, Orosan P . Cognitive-behavioral body image therapy for body dysmorphic disorder. J Consult Clin Psychol. 1995; 63(2):263-9. DOI: 10.1037//0022-006x.63.2.263. View

19.

Wilhelm S, Phillips K, Didie E, Buhlmann U, Greenberg J, Fama J . Modular cognitive-behavioral therapy for body dysmorphic disorder: a randomized controlled trial. Behav Ther. 2014; 45(3):314-27. PMC: 4283214. DOI: 10.1016/j.beth.2013.12.007. View

20.

Reed G, First M, Kogan C, Hyman S, Gureje O, Gaebel W . Innovations and changes in the ICD-11 classification of mental, behavioural and neurodevelopmental disorders. World Psychiatry. 2019; 18(1):3-19. PMC: 6313247. DOI: 10.1002/wps.20611. View